National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 6/24/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Jeremy S. Abramson, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Constellation, Inc.;
Seattle Genetics

Genentech, Inc.;
Seattle Genetics, Inc.;
Spectrum Pharmaceuticals

Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.

None

None

Ranjana H. Advani, MD

Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Agensys;
Allos Therapeutics;
Idera Pharmaceuticals;
Seattle Genetics;
Pharmacyclics

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Clarient;
Seattle Genetics

None

None

None

C. Babis Andreadis, MD, MSCE

GlaxoSmithKline

None

Millennium Pharmaceuticals, Inc.;
Spectrum;
Pharmacyclics

None

Genentech, Inc.;
Roche Laboratories, Inc.

Nancy Bartlett, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
MedImmune Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.;
Pharmacyclics

None

Seattle Genetics

None

None

John C. Byrd, MD

None

None

Genentech, Inc.;
Pharmacyclics

None

None

Myron S. Czuczman, MD

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead

Boehringer Ingelheim GmbH;
Celgene Corporation;
Algeta;
Mundipharma;
Teva

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Luis E. Fayad, MD

Centocor, Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

None

None

None

None

Richard I. Fisher, MD

None

Johnson & Johnson;
Coherus Bioscience;
Giliad

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Martha J. Glenn, MD

Amgen Inc.;
Institutional DSMC;
sanofi-aventis U.S.

None

None

None

None

Leo I. Gordon, MD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Nancy Lee Harris, MD

Pharmacyclics

None

None

None

None

Richard T. Hoppe, MD

None

Clarient

Clarient

None

None

Steven M. Horwitz, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
;
Infinity;
Kiowa-Kirin;
Seattle Genetics;
spectrum

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Actelion;
Kiowa Hakka Kirin;
Spectrum

Celgene Corporation

None

None

Christopher R. Kelsey, MD

Varian Medical Systems, Inc.

None

None

None

None

Youn H. Kim, MD

None

Celgene Corporation;
Eisai Inc.;
Millennium Pharmaceuticals, Inc.;
Actelion;
Galderma

None

None

None

Susan Krivacic, MPAff

None

None

None

None

None

Ann S. LaCasce, MD

None

GlaxoSmithKline

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Auayporn Nademanee, MD

None

None

None

None

None

Elise A. Olsen, MD

None

Merck & Co., Inc.

None

None

None

Pierluigi Porcu, MD

Infinity;
OncoMed;
Seattle Genetics

Celgene Corporation;
Actelion

Celgene Corporation;
Actelion

None

None

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

Algeta;
BIND Biosciences

None

Emergent Biosolutions

None

Rachel Rabinovitch, MD

RTOG Data Safety and Monitoring Board

Accuray Incorporated

None

None

None

Nishitha Reddy, MD

Celgene Corporation

Celgene Corporation

None

None

None

Erin Reid, MD

Bristol-Myers Squibb Company;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Abbvie Pharmaceuticals;
AIDS Malignancy Consortium;
CALGB/CTSU;
Isis;
Pharmacyclics;
Takeda Pharmaceuticals North America, Inc.

None

Seattle Genetics

None

None

Ayman A. Saad, MD

None

IMS Consulting Group

None

None

None

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Spectrum

Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.

None

None

Hema Sundar, PhD

None

None

None

None

None

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Christina Tsien, MD

None

None

None

None

None

Julie M. Vose, MD, MBA

Bristol-Myers Squibb Company;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.;
Incyte;
US Biotest;
US Biotest, Inc.;
Pharmacyclics;
sanofi-aventis U.S.

None

None

None

None

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

Joachim Yahalom, MD

None

None

None

None

None

Nadeem Zafar, MD

None

None

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Amgen Inc.;
Celgene Corporation;
Genentech, Inc.;
Bullet Bio Technology;
Cancer Genetics;
Dr. Reddy`s Laboratories;
Emergent Biosolutions;
Foundation Medicine;
Gilead;
Hospira;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None